| Year |
Citation |
Score |
| 2021 |
Zabroski IO, Nugent MA. Lipid Raft Association Stabilizes VEGF Receptor 2 in Endothelial Cells. International Journal of Molecular Sciences. 22. PMID 33466887 DOI: 10.3390/ijms22020798 |
0.339 |
|
| 2019 |
Buczek-Thomas JA, Rich CB, Nugent MA. Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions. International Journal of Molecular Sciences. 20. PMID 31614727 DOI: 10.3390/Ijms20205065 |
0.782 |
|
| 2019 |
Tsiros D, Sheehy CE, Pecchia S, Nugent MA. Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH. The Journal of Biological Chemistry. PMID 31601651 DOI: 10.1074/jbc.RA119.009194 |
0.455 |
|
| 2018 |
Teran M, Nugent MA. Characterization of receptor binding kinetics for vascular endothelial growth factor-A using SPR. Analytical Biochemistry. PMID 30292477 DOI: 10.1016/J.Ab.2018.10.001 |
0.811 |
|
| 2016 |
Sack KD, Teran M, Nugent MA. Extracellular Matrix Stiffness Controls VEGF Signaling and Processing in Endothelial Cells. Journal of Cellular Physiology. PMID 26773314 DOI: 10.1002/Jcp.25312 |
0.833 |
|
| 2015 |
Kurtagic E, Rich CB, Buczek-Thomas JA, Nugent MA. Neutrophil Elastase-Generated Fragment of Vascular Endothelial Growth Factor-A Stimulates Macrophage and Endothelial Progenitor Cell Migration. Plos One. 10: e0145115. PMID 26672607 DOI: 10.1371/Journal.Pone.0145115 |
0.824 |
|
| 2015 |
Hubbard B, Buczek-Thomas JA, Nugent MA, Smith ML. Fibronectin Fiber Extension Decreases Cell Spreading and Migration. Journal of Cellular Physiology. PMID 26621030 DOI: 10.1002/Jcp.25271 |
0.788 |
|
| 2015 |
Derricks KE, Trinkaus-Randall V, Nugent MA. Extracellular matrix stiffness modulates VEGF calcium signaling in endothelial cells: individual cell and population analysis. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 1011-25. PMID 26183123 DOI: 10.1039/C5Ib00140D |
0.338 |
|
| 2015 |
Teran M, Nugent MA. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. The Journal of Biological Chemistry. 290: 16451-62. PMID 25979342 DOI: 10.1074/Jbc.M114.627372 |
0.838 |
|
| 2015 |
Sazonova OV, Isenberg BC, Herrmann J, Lee KL, Purwada A, Valentine AD, Buczek-Thomas JA, Wong JY, Nugent MA. Extracellular matrix presentation modulates vascular smooth muscle cell mechanotransduction. Matrix Biology : Journal of the International Society For Matrix Biology. 41: 36-43. PMID 25448408 DOI: 10.1016/J.Matbio.2014.11.001 |
0.812 |
|
| 2014 |
Mao Y, Huang Y, Buczek-Thomas JA, Ethen CM, Nugent MA, Wu ZL, Zaia J. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase. The Journal of Biological Chemistry. 289: 34141-51. PMID 25336655 DOI: 10.1074/Jbc.M114.589630 |
0.766 |
|
| 2014 |
Huang Y, Mao Y, Buczek-Thomas JA, Nugent MA, Zaia J. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches. Plos One. 9: e105143. PMID 25127119 DOI: 10.1371/Journal.Pone.0105143 |
0.718 |
|
| 2014 |
Hubbard B, Buczek-Thomas JA, Nugent MA, Smith ML. Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biology : Journal of the International Society For Matrix Biology. 34: 124-31. PMID 24148804 DOI: 10.1016/J.Matbio.2013.10.006 |
0.815 |
|
| 2013 |
Nugent MA, Zaia J, Spencer JL. Heparan sulfate-protein binding specificity. Biochemistry. Biokhimii͡A. 78: 726-35. PMID 24010836 DOI: 10.1134/S0006297913070055 |
0.806 |
|
| 2013 |
Derricks KE, Rich CB, Buczek-Thomas JA, Nugent MA. Ascorbate enhances elastin synthesis in 3D tissue-engineered pulmonary fibroblasts constructs. Tissue & Cell. 45: 253-60. PMID 23648172 DOI: 10.1016/J.Tice.2013.03.001 |
0.705 |
|
| 2013 |
Imsirovic J, Derricks K, Buczek-Thomas JA, Rich CB, Nugent MA, Suki B. A novel device to stretch multiple tissue samples with variable patterns: application for mRNA regulation in tissue-engineered constructs. Biomatter. 3. PMID 23628870 DOI: 10.4161/biom.24650 |
0.711 |
|
| 2012 |
Fannon M, Forsten-Williams K, Zhao B, Bach E, Parekh PP, Chu CL, Goerges-Wildt AL, Buczek-Thomas JA, Nugent MA. Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. Journal of Cellular Physiology. 227: 3693-700. PMID 22378222 DOI: 10.1002/Jcp.24077 |
0.813 |
|
| 2011 |
Forsten-Williams K, Kurtagic E, Nugent MA. Complex receptor-ligand dynamics control the response of the VEGF system to protease injury. Bmc Systems Biology. 5: 170. PMID 22014244 DOI: 10.1186/1752-0509-5-170 |
0.832 |
|
| 2011 |
Sazonova OV, Lee KL, Isenberg BC, Rich CB, Nugent MA, Wong JY. Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophysical Journal. 101: 622-30. PMID 21806930 DOI: 10.1016/J.Bpj.2011.06.051 |
0.746 |
|
| 2011 |
Araújo AD, Majumdar A, Parameswaran H, Yi E, Spencer JL, Nugent MA, Suki B. Dynamics of enzymatic digestion of elastic fibers and networks under tension. Proceedings of the National Academy of Sciences of the United States of America. 108: 9414-9. PMID 21606336 DOI: 10.1073/Pnas.1019188108 |
0.761 |
|
| 2011 |
Naimy H, Buczek-Thomas JA, Nugent MA, Leymarie N, Zaia J. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. The Journal of Biological Chemistry. 286: 19311-9. PMID 21471211 DOI: 10.1074/Jbc.M110.204693 |
0.781 |
|
| 2010 |
Symes K, Smith EM, Mitsi M, Nugent MA. Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adhesion & Migration. 4: 507-10. PMID 20562530 DOI: 10.4161/Cam.4.4.12427 |
0.809 |
|
| 2010 |
Guarnieri F, Spencer JL, Lucey EC, Nugent MA, Stone PJ. A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema. Proceedings of the National Academy of Sciences of the United States of America. 107: 10661-6. PMID 20534582 DOI: 10.1073/Pnas.1001349107 |
0.752 |
|
| 2010 |
Spencer JL, Bernanke JA, Buczek-Thomas JA, Nugent MA. A computational approach for deciphering the organization of glycosaminoglycans. Plos One. 5: e9389. PMID 20186334 DOI: 10.1371/Journal.Pone.0009389 |
0.784 |
|
| 2010 |
Vora SR, Palamakumbura AH, Mitsi M, Guo Y, Pischon N, Nugent MA, Trackman PC. Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. The Journal of Biological Chemistry. 285: 7384-93. PMID 20048148 DOI: 10.1074/Jbc.M109.033597 |
0.792 |
|
| 2009 |
Smith EM, Mitsi M, Nugent MA, Symes K. PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proceedings of the National Academy of Sciences of the United States of America. 106: 21683-8. PMID 19966216 DOI: 10.1073/Pnas.0902510106 |
0.8 |
|
| 2009 |
Palamakumbura AH, Vora SR, Nugent MA, Kirsch KH, Sonenshein GE, Trackman PC. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene. 28: 3390-400. PMID 19597471 DOI: 10.1038/Onc.2009.203 |
0.312 |
|
| 2009 |
Ritter MC, Jesudason R, Majumdar A, Stamenovic D, Buczek-Thomas JA, Stone PJ, Nugent MA, Suki B. A zipper network model of the failure mechanics of extracellular matrices. Proceedings of the National Academy of Sciences of the United States of America. 106: 1081-6. PMID 19144920 DOI: 10.1073/Pnas.0808414106 |
0.681 |
|
| 2009 |
Kurtagic E, Jedrychowski MP, Nugent MA. Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. American Journal of Physiology. Lung Cellular and Molecular Physiology. 296: L534-46. PMID 19136576 DOI: 10.1152/Ajplung.90505.2008 |
0.829 |
|
| 2009 |
Smith EM, Mitsi M, Nugent MA, Symes K. PDGF-AA interactions with fibronectin reveal a potential role for heparan sulfate in mediating directed cell migration during Xenopus laevis gastrulation Developmental Biology. 331: 472. DOI: 10.1016/J.Ydbio.2009.05.318 |
0.765 |
|
| 2009 |
Sazonova OV, Rich CB, Wong JY, Nugent MA. In VSMCs, Beta-1 Integrin but not Syndecan-4 Gene Expression is Dependent on Matrix Stiffness Biophysical Journal. 96: 673a. DOI: 10.1016/J.Bpj.2008.12.3559 |
0.662 |
|
| 2009 |
Suki B, Ritter MC, Majumdar A, Jesudason R, Stamenovic D, Buczek-Thomas JA, Stone PJ, Nugent MA. A Zipper Network Model of Extracellular Matrix Failure Reveals a New Role for Proteoglycans Biophysical Journal. 96: 317a. DOI: 10.1016/J.Bpj.2008.12.1585 |
0.687 |
|
| 2008 |
Mitsi M, Forsten-Williams K, Gopalakrishnan M, Nugent MA. A catalytic role of heparin within the extracellular matrix. The Journal of Biological Chemistry. 283: 34796-807. PMID 18845539 DOI: 10.1074/Jbc.M806692200 |
0.844 |
|
| 2008 |
Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA. Control of growth factor networks by heparan sulfate proteoglycans. Annals of Biomedical Engineering. 36: 2134-48. PMID 18839312 DOI: 10.1007/S10439-008-9575-Z |
0.819 |
|
| 2008 |
Baker AB, Ettenson DS, Jonas M, Nugent MA, Iozzo RV, Edelman ER. Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circulation Research. 103: 289-97. PMID 18583708 DOI: 10.1161/Circresaha.108.179465 |
0.647 |
|
| 2008 |
Buczek-Thomas JA, Hsia E, Rich CB, Foster JA, Nugent MA. Inhibition of histone acetyltransferase by glycosaminoglycans. Journal of Cellular Biochemistry. 105: 108-20. PMID 18459114 DOI: 10.1002/Jcb.21803 |
0.786 |
|
| 2008 |
Fannon M, Forsten-Williams K, Nugent MA, Gregory KJ, Chu CL, Goerges-Wildt AL, Panigrahy D, Kaipainen A, Barnes C, Lapp C, Shing Y. Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth. Journal of Cellular Physiology. 215: 434-41. PMID 18163458 DOI: 10.1002/Jcp.21327 |
0.828 |
|
| 2008 |
Smith EM, Mitsi M, Nugent MA, Symes K. The role of PDGF-AA-fibronectin interactions in the directed migration of mesendoderm cells during gastrulation Developmental Biology. 319: 539. DOI: 10.1016/J.Ydbio.2008.05.262 |
0.753 |
|
| 2006 |
Mitsi M, Hong Z, Costello CE, Nugent MA. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry. 45: 10319-28. PMID 16922507 DOI: 10.1021/Bi060974P |
0.825 |
|
| 2006 |
Spencer JL, Stone PJ, Nugent MA. New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry. 45: 9104-20. PMID 16866356 DOI: 10.1021/Bi060338R |
0.785 |
|
| 2005 |
Gopalakrishnan M, Forsten-Williams K, Nugent MA, Täuber UC. Effects of receptor clustering on ligand dissociation kinetics: theory and simulations. Biophysical Journal. 89: 3686-700. PMID 16150967 DOI: 10.1529/Biophysj.105.065300 |
0.721 |
|
| 2005 |
Chu CL, Goerges AL, Nugent MA. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry. 44: 12203-13. PMID 16142919 DOI: 10.1021/Bi050241P |
0.818 |
|
| 2005 |
Forsten-Williams K, Chua CC, Nugent MA. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. Journal of Theoretical Biology. 233: 483-99. PMID 15748910 DOI: 10.1016/J.Jtbi.2004.10.020 |
0.789 |
|
| 2005 |
Nugent MA, Forsten-Williams K, Karnovsky MJ, Edelman ER. Mechanisms of cell growth regulation by heparin and heparan sulfate Chemistry and Biology of Heparin and Heparan Sulfate. 533-570. DOI: 10.1016/B978-008044859-6/50020-4 |
0.651 |
|
| 2004 |
Buczek-Thomas JA, Lucey EC, Stone PJ, Chu CL, Rich CB, Carreras I, Goldstein RH, Foster JA, Nugent MA. Elastase mediates the release of growth factors from lung in vivo. American Journal of Respiratory Cell and Molecular Biology. 31: 344-50. PMID 15191913 DOI: 10.1165/Rcmb.2003-0420Oc |
0.776 |
|
| 2004 |
Chu CL, Buczek-Thomas JA, Nugent MA. Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. The Biochemical Journal. 379: 331-41. PMID 14717658 DOI: 10.1042/Bj20031082 |
0.812 |
|
| 2004 |
Chua CC, Rahimi N, Forsten-Williams K, Nugent MA. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circulation Research. 94: 316-23. PMID 14684627 DOI: 10.1161/01.Res.0000112965.70691.Ac |
0.755 |
|
| 2004 |
Goerges AL, Nugent MA. pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. The Journal of Biological Chemistry. 279: 2307-15. PMID 14570917 DOI: 10.1074/Jbc.M308482200 |
0.839 |
|
| 2003 |
Liu J, Rich CB, Buczek-Thomas JA, Nugent MA, Panchenko MP, Foster JA. Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts. American Journal of Physiology. Lung Cellular and Molecular Physiology. 285: L1106-15. PMID 12882762 DOI: 10.1152/Ajplung.00180.2003 |
0.777 |
|
| 2003 |
Rich CB, Carreras I, Lucey EC, Jaworski JA, Buczek-Thomas JA, Nugent MA, Stone P, Foster JA. Transcriptional regulation of pulmonary elastin gene expression in elastase-induced injury. American Journal of Physiology. Lung Cellular and Molecular Physiology. 285: L354-62. PMID 12679320 DOI: 10.1152/Ajplung.00026.2003 |
0.7 |
|
| 2003 |
Hsia E, Richardson TP, Nugent MA. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling. Journal of Cellular Biochemistry. 88: 1214-25. PMID 12647303 DOI: 10.1002/Jcb.10470 |
0.8 |
|
| 2003 |
Goerges AL, Nugent MA. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. The Journal of Biological Chemistry. 278: 19518-25. PMID 12637571 DOI: 10.1074/Jbc.M211208200 |
0.821 |
|
| 2003 |
Fannon M, Forsten-Williams K, Dowd CJ, Freedman DA, Folkman J, Nugent MA. Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 902-4. PMID 12626427 DOI: 10.1096/Fj.02-0935Fje |
0.828 |
|
| 2002 |
Buczek-Thomas JA, Chu CL, Rich CB, Stone PJ, Foster JA, Nugent MA. Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. Journal of Cellular Physiology. 192: 294-303. PMID 12124775 DOI: 10.1002/jcp.10135 |
0.82 |
|
| 2001 |
Forsten KE, Nugent MA. Binding constant measurements for inhibitors of growth factor binding to heparan sulfate proteoglycans Methods in Molecular Biology (Clifton, N.J.). 171: 415-426. PMID 11450256 |
0.361 |
|
| 2001 |
Richardson TP, Trinkaus-Randall V, Nugent MA. Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin Journal of Cell Science. 114: 1613-1623. PMID 11309193 |
0.318 |
|
| 2000 |
Forsten KE, Fannon M, Nugent MA. Potential mechanisms for the regulation of growth factor binding by heparin. Journal of Theoretical Biology. 205: 215-30. PMID 10873433 DOI: 10.1006/Jtbi.2000.2064 |
0.825 |
|
| 2000 |
Nugent MA, Nugent HM, Iozzo RV, Sanchack K, Edelman ER. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. 97: 6722-7. PMID 10841569 DOI: 10.1073/Pnas.97.12.6722 |
0.669 |
|
| 2000 |
Sperinde GV, Nugent MA. Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans. Biochemistry. 39: 3788-96. PMID 10736179 |
0.828 |
|
| 2000 |
Song QH, Singh RP, Richardson TP, Nugent MA, Trinkaus-Randall V. Transforming growth factor-β1 expression in cultured corneal fibroblasts in response to injury Journal of Cellular Biochemistry. 77: 186-199. PMID 10723086 DOI: 10.1002/(Sici)1097-4644(20000501)77:2<186::Aid-Jcb3>3.0.Co;2-M |
0.61 |
|
| 2000 |
Nugent MA, Iozzo RV. Fibroblast growth factor-2 International Journal of Biochemistry and Cell Biology. 32: 115-120. PMID 10687947 DOI: 10.1016/S1357-2725(99)00123-5 |
0.4 |
|
| 2000 |
Fannon M, Forsten KE, Nugent MA. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry. 39: 1434-45. PMID 10684625 DOI: 10.1021/Bi991895Z |
0.812 |
|
| 2000 |
Forsten KE, Wang N, Robinson RM, Nugent MA. A simple assay for evaluating inhibitors of proteoglycan-ligand binding. Annals of Biomedical Engineering. 28: 119-27. PMID 10645795 DOI: 10.1114/1.260 |
0.45 |
|
| 1999 |
Natke B, Venkataraman G, Nugent MA, Sasisekharan R. Heparinase treatment of bovine smooth muscle cells inhibits fibroblast growth factor-2 binding to fibroblast growth factor receptor but not FGF-2 mediated cellular proliferation. Angiogenesis. 3: 249-57. PMID 14517424 DOI: 10.1023/A:1009008824246 |
0.404 |
|
| 1999 |
Rich CB, Fontanilla MR, Nugent M, Foster JA. Basic fibroblast growth factor decreases elastin gene transcription through an AP1/cAMP-response element hybrid site in the distal promoter. The Journal of Biological Chemistry. 274: 33433-9. PMID 10559225 DOI: 10.1074/Jbc.274.47.33433 |
0.428 |
|
| 1999 |
Buczek-Thomas JA, Nugent MA. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury. The Journal of Biological Chemistry. 274: 25167-72. PMID 10455199 DOI: 10.1074/Jbc.274.35.25167 |
0.772 |
|
| 1999 |
Richardson TP, Trinkaus-Randall V, Nugent MA. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate Journal of Biological Chemistry. 274: 13534-13540. PMID 10224122 DOI: 10.1074/Jbc.274.19.13534 |
0.71 |
|
| 1999 |
Dowd CJ, Cooney CL, Nugent MA. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. The Journal of Biological Chemistry. 274: 5236-44. PMID 9988774 DOI: 10.1074/Jbc.274.8.5236 |
0.78 |
|
| 1998 |
Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. The Journal of Clinical Investigation. 102: 1599-608. PMID 9788974 DOI: 10.1172/Jci3793 |
0.312 |
|
| 1998 |
Sperinde GV, Nugent MA. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry. 37: 13153-64. PMID 9748322 DOI: 10.1021/bi980600z |
0.834 |
|
| 1998 |
Buczek-Thomas J, Nugent MA. Effect of elastase on bFGF and bFGF receptor function in neonatal rat lung fibroblast matrices Faseb Journal. 12. |
0.352 |
|
| 1997 |
Forsten KE, Courant NA, Nugent MA. Endothelial proteoglycans inhibit bFGF binding and mitogenesis. Journal of Cellular Physiology. 172: 209-20. PMID 9258342 DOI: 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S |
0.44 |
|
| 1996 |
Nehra A, Goldstein I, Pabby A, Nugent M, Huang Y, Morenas Adl, Krane RJ, Udelson D, Tejada ISd, Moreland RB. Mechanisms of Venous Leakage: A Prospective Clinicopathological Correlation of Corporeal Function and Structure The Journal of Urology. 156: 1320-1329. PMID 8808863 DOI: 10.1016/S0022-5347(01)65578-2 |
0.323 |
|
| 1996 |
Fannon M, Nugent MA. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate Journal of Biological Chemistry. 271: 17949-17956. PMID 8663512 DOI: 10.1074/Jbc.271.30.17949 |
0.791 |
|
| 1995 |
Nathan A, Nugent MA, Edelman ER. Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proceedings of the National Academy of Sciences of the United States of America. 92: 8130-4. PMID 7667257 DOI: 10.1073/Pnas.92.18.8130 |
0.659 |
|
| 1994 |
Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R. Heparinase inhibits neovascularization. Proceedings of the National Academy of Sciences of the United States of America. 91: 1524-8. PMID 7509076 DOI: 10.1073/Pnas.91.4.1524 |
0.615 |
|
| 1993 |
Edelman ER, Nugent MA, Karnovsky MJ. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proceedings of the National Academy of Sciences of the United States of America. 90: 1513-7. PMID 8434012 DOI: 10.1073/Pnas.90.4.1513 |
0.602 |
|
| 1993 |
Nugent MA, Karnovsky MJ, Edelman ER. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circulation Research. 73: 1051-60. PMID 8222077 DOI: 10.1161/01.Res.73.6.1051 |
0.711 |
|
| 1993 |
Hobbs SK, Periolat LM, Cima LG, Nugent M, Leunig M, Jain RK. The Development of an In Situ Assay for bFGF Release Mrs Proceedings. 331. DOI: 10.1557/Proc-331-187 |
0.347 |
|
| 1992 |
Nugent MA, Edelman ER. Transforming growth factor beta 1 stimulates the production of basic fibroblast growth factor binding proteoglycans in Balb/c3T3 cells. The Journal of Biological Chemistry. 267: 21256-64. PMID 1400436 |
0.307 |
|
| 1992 |
Nugent MA, Edelman ER. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry. 31: 8876-83. PMID 1390674 DOI: 10.1021/Bi00152A026 |
0.632 |
|
| 1992 |
Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. The Journal of Clinical Investigation. 89: 465-73. PMID 1371124 DOI: 10.1172/Jci115607 |
0.611 |
|
| 1991 |
Nugent MA, Chen OS, Edelman ER. Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture Mrs Proceedings. 252. DOI: 10.1557/Proc-252-273 |
0.654 |
|
| Show low-probability matches. |